Clinical trial · Interventional
Use of a Comprehensive, Mobile Application to Assist Cancer Patients With Diet, Nutrition and Activity
NCT06860425CI-TRIAL-00103959recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The overarching purpose of this study is to assess whether patients will use the app throughout treatment on a regular basis, as the ultimate goal is to provide an educational platform that can impact patient behaviors and understanding towards health.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer Patients | — | UNRESOLVED | — |
| Mobile Applications | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| RestoreMe | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- OTHER
- label
- Active Treatment
- description
- 25 patients who prior to initiation of curative treatment.
- interventionNames
- Other: RestoreMe
- type
- OTHER
- label
- Follow-up/Survivorship Care
- description
- 25 patients who are in post-radiation therapy follow-up/survivorship care after completing definitive treatment.
- interventionNames
- Other: RestoreMe
Primary outcomes (1)
- measure
- Patient Satisfaction
- timeFrame
- Upon completion of treatment regimen or up to 12 months (+/1 month) after study entry
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Diagnosis of invasive malignancy of the brain, head and neck region, lung, breast (DCIS and invasive disease allowed), prostate, gastrointestinal system or gynecological region * Planned to receive, or have received, radiation therapy treatment with curative intent * Note: Patients undergoing systemic therapy are eligible * Note: Any dose/fractionation of curative-intent radiation therapy is eligible * Patients must have a smartphone or other device with the ability to receive text messages, download and use mobile applications * Eastern Cooperative Oncology Group (ECOG) performance status 0-2 * Ability to read and write in English * Provide written informed consent to participate in the study o NOTE: Patients enrolled on another clinical trial are eligible Exclusion Criteria: * Metastatic cancer * Undergoing treatment with palliative intent * Poorly controlled diabetes (defined as fasting glucose level \> 200 mg/dL despite attempts to improve glucose control by fasting duration and adjustment of medications) * Uncontrolled hypertension * Any medical condition requiring fluid restriction or nutrient restrictions
References
Publications (35)
- BACKGROUNDGagnon MP, Ngangue P, Payne-Gagnon J, Desmartis M. m-Health adoption by healthcare professionals: a systematic review. J Am Med Inform Assoc. 2016 Jan;23(1):212-20. doi: 10.1093/jamia/ocv052. Epub 2015 Jun 15. PMID 26078410
- BACKGROUNDKamdar, Mihir M., et al.
- BACKGROUNDLiu, Patrick, et al.
- BACKGROUNDMielck A, Vogelmann M, Leidl R. Health-related quality of life and socioeconomic status: inequalities among adults with a chronic disease. Health Qual Life Outcomes. 2014 Apr 25;12:58. doi: 10.1186/1477-7525-12-58. PMID 24761773
- BACKGROUNDNYS DOH. 2013-2014 NYS Expanded Behavioral Risk Factor Surveillance System, data as of 2015. Available: https://www.health.ny.gov/statistics/chac/general/g75.htm. Accessed 23 September 2016.
- BACKGROUNDPierce JP, Faerber S, Wright FA, Rock CL, Newman V, Flatt SW, Kealey S, Jones VE, Caan BJ, Gold EB, Haan M, Hollenbach KA, Jones L, Marshall JR, Ritenbaugh C, Stefanick ML, Thomson C, Wasserman L, Natarajan L, Thomas RG, Gilpin EA; Women's Healthy Eating and Living (WHEL) study group. A randomized trial of the effect of a plant-based dietary pattern on additional breast cancer events and survival: the Women's Healthy Eating and Living (WHEL) Study. Control Clin Trials. 2002 Dec;23(6):728-56. doi: 10.1016/s0197-2456(02)00241-6. PMID 12505249
- BACKGROUNDChan DSM, Vieira AR, Aune D, Bandera EV, Greenwood DC, McTiernan A, Navarro Rosenblatt D, Thune I, Vieira R, Norat T. Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies. Ann Oncol. 2014 Oct;25(10):1901-1914. doi: 10.1093/annonc/mdu042. Epub 2014 Apr 27. PMID 24769692
- BACKGROUNDProtani M, Coory M, Martin JH. Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat. 2010 Oct;123(3):627-35. doi: 10.1007/s10549-010-0990-0. Epub 2010 Jun 23.